MINT:CA:TSX-Manulife Multifactor Developed International Index ETF (CAD)

ETF | International Equity |

Last Closing

CAD 38.31

Change

0.00 (0.00)%

Market Cap

CAD 0.52B

Volume

218.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for International Equity

Symbol Name Price(Change) Market Cap
XEF:CA iShares Core MSCI EAFE IMI

+0.13 (+0.34%)

CAD 8.76B
ZEA:CA BMO MSCI EAFE

+0.10 (+0.43%)

CAD 8.40B
XFH:CA iShares Core MSCI EAFE IMI Ind..

-0.01 (-0.03%)

CAD 1.45B
XIN:CA iShares MSCI EAFE (CAD Hedged)

+0.03 (+0.08%)

CAD 1.36B
QDX:CA Mackenzie International Equity..

+0.81 (+0.67%)

CAD 0.94B
ZDM:CA BMO MSCI EAFE (CAD Hedged)

+0.03 (+0.10%)

CAD 0.85B
VEF:CA Vanguard FTSE Developed All Ca..

+0.03 (+0.05%)

CAD 0.63B
FCIQ:CA Fidelity International High Qu..

+0.10 (+0.26%)

CAD 0.60B
HXDM:CA Global X Intl Developed Market..

+0.09 (+0.19%)

CAD 0.55B
ZDI:CA BMO International Dividend Uni..

N/A

CAD 0.50B

ETFs Containing MINT:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (International Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.09% 14% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.09% 14% F 51% F
Trailing 12 Months  
Capital Gain 16.62% 86% B+ 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.62% 86% B+ 62% D
Trailing 5 Years  
Capital Gain 46.67% 86% B+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.67% 86% B+ 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.29% N/A N/A 70% C-
Dividend Return 10.04% N/A N/A 67% D+
Total Return 0.75% N/A N/A 32% F
Risk Return Profile  
Volatility (Standard Deviation) 12.62% N/A N/A 63% D
Risk Adjusted Return 79.56% N/A N/A 90% A-
Market Capitalization 0.52B 62% D 59% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike